{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-045553","form_type":"8-K","ticker":"PURR","cik":"0002078856","company_name":"Hyperliquid Strategies Inc","filed_at":"2026-02-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.197697+00:00","generated_at":"2026-05-16T03:25:09.942953+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"confidence":"high","headline":"Hyperliquid Strategies reports $317.9M net loss for H1 FY2026; HYPE holdings 17.6M","bullets":["Six-month net loss of $317.9M, driven by $262.4M unrealized loss on HYPE tokens and $35.6M IPR&D write-off.","Revenue from interest ($0.9M) and staking ($0.5M); total assets $616.7M with no debt and stockholders' equity $589.8M.","Treasury deployed $129.5M to acquire 5M HYPE tokens, raising total holdings to 17.6M; $125M deployable capital remains.","Repurchased 3M PURR shares for $10.5M, reducing diluted share count to 150.6M.","Completed NASDAQ listing Dec 2, 2025 via business combination with Sonnet BioTherapeutics."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-045553","json":"https://secwatch.observer/filing/0001193125-26-045553.json","markdown":"https://secwatch.observer/filing/0001193125-26-045553.md","text":"https://secwatch.observer/filing/0001193125-26-045553.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2078856/000119312526045553/0001193125-26-045553-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2078856/000119312526045553/purr-20260211.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T03:25:09.942953+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}